EFNB2 and neoplasm: In this study, we sought to examine vascular ephrinB2 from a metastatic angle and incorporated RT due to the ability of RT to enhance anti-tumor immunity [94–99] and its use as a standard-of-care therapy for HNSCC patients [24, 25].